← Back to medicines

Lacomax IV 50 mg/5 ml is a Product of the Generic Lacosamide

Lacomax IV 50 mg/5 ml belongs to the generic category of Lacosamide. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Lacomax IV 50 mg/5 ml. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Lacosamide and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Medicine Image
Rx

*Up to 10% Discount

(Depends on pharmacy)

Lacomax IV 50 mg/5 ml

Incepta Pharmaceuticals Ltd. · IV Injection

Generic

Lacosamide

Strength50 mg/5 ml
Total Strip1
Strip Size5
Unit Price
৳ 60

/ 5 ml vial

Order Now

Description of Lacomax IV 50 mg/5 ml

Lacomax IV 50 mg/5 ml may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Lacomax IV 50 mg/5 ml is provided below to help users gain a clear understanding of this medicine.

What Is Lacomax IV 50 mg/5 ml Indications and Uses?

Lacomax is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Lacomax is indicated for adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.


Pharmacology (Source, Chemical and Physical Composition) Of Lacomax IV 50 mg/5 ml

It is proposed that Lacomax IV 50 mg/5 ml (Lacosamide)'s inhibition of sodium channels is responsible for analgesia. Lacosamide may be selective for inhibiting depolarized neurons rather than neurons with normal resting potentials. Pain and nociceptor hyperexcitability are associated with neural membrane depolarization. Lacosamide binds to collapsin response mediator protein-2 (CRMP-2), a phosphoprotein which is expressed primarily in the nervous system and is involved in neuronal differentiation and control of axonal outgrowth. The role CRMP-2 of binding in seizure control is hasn't been elucidated. The precise mechanism by which Lacosamide exerts its anti-epileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies have shown that Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes and inhibition of repetitive neuronal firing.


Dosage And Administration of Lacomax IV 50 mg/5 ml

Recommended Dosages for Partial-Onset Seizures (Monotherapy or Adjunctive Therapy) in Patients 1 Month and Older, and for Primary Generalized Tonic-Clonic Seizures (Adjunctive Therapy) in Patients 4 Years of Age and Older. Age and Body Weight Initial Dosage Titration (Incremental Steps) Maintenance Dosage Adults (≥17 years) Monotherapy: 100 mg twice daily (200 mg per day) Adjunctive therapy: 50 mg twice daily (100 mg per day) Increase by 50 mg twice daily (100 mg per day) every week Monotherapy: 150-200 mg twice daily (300-400 mg per day) Adjunctive therapy: 100-200 mg twice daily (200-400 mg per day) Pediatric patients (≥50 kg) 50 mg twice daily (100 mg per day) Pediatric patients (30-50 kg) 1 mg/kg twice daily (2 mg/kg per day) Increase by 1 mg/kg twice daily (2 mg/kg/day) every week 2-4 mg/kg twice daily (4-8 mg/kg/day) Pediatric patients (6-30 kg) 3-6 mg/kg twice daily (6-12 mg/kg/day) Pediatric patients <6 kg) 3.75-7.5 mg/kg twice daily (7.5-15 mg/kg/day) Lacomax IV 50 mg/5 ml (Lacosamide) tablets and oral solution may be taken with or without food.


Drug Interactions of Lacomax IV 50 mg/5 ml

Dose reduction of Lacomax may be necessary in patients with renal or hepatic impairment who are taking strong inhibitors of CYP3A4 & CYP2C9. Lacomax should be used with caution in patients who are on concomitant medications that affect cardiac conduction (sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers) including those that prolong PR interval (sodium channel blocking AEDs)


Side Effects of Lacomax IV 50 mg/5 ml

The most common adverse reactions of Lacomax are dizziness, headache, somnolence, ataxia, tremor, nausea, vomiting, fatigue, diplopia, blurred vision etc.


Precautions And Warnings for Lacomax IV 50 mg/5 ml

Monitor patients for Suicidal behavior, Dizziness, Ataxia, PR interval prolongation, Atrioventricular block, Ventricular tachyarrhythmia, Atrial fibrillation, Atrial flutter, Syncope, Phenylketonuria, Multi-organ hypersensitivity etc. when Lacomax is prescribed.


Use During Pregnancy and Lactation

Pregnancy : There are no adequate and well-controlled studies in pregnant women and Lacomax IV 50 mg/5 ml (Lacosamide) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation : Lacosamide is excreted in human breast milk. The known benefits of breastfeeding should be weighed against the unknown risks of infant exposure to Lacosamide.


Therapeutic Class

Atypical anti-depressant drugs


Storage Conditions of It

Do not store above 30°C. Keep away from light and out of the reach of children. Pack Image: Lacomax 50 mg/5 ml Injection Thanks for using MedEx! How would you rate your experience so far?


Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.

Alternative Medicines

⚠ Disclaimer

The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

All Samadhan logo

N.B.: All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines.

Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved

DBID

Registration ID: 176322642

Trade License: TRAD/DNCC/040904/2023

Payment Methods
google play storeapple store
Chat with us